Early Access — free while we kick the tires
EdgarHawk

Patterson Chad

Chief Commercial Officer

Officer
2 filings analyzed · 1 company · Latest 2025-05-05

Never miss a filing from Patterson Chad

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
iRhythm Technologies, Inc. IRTC 1 1 Neutral

Activity

May 2025
medium
Sell
8,510 shares
$1,025,898
Significance 5/10

CCO Patterson sells 8,510 shares at avg $120.55 as IRTC hits 52-week high of $135.76; post-sale holdings 49,930 shares

Patterson Chad, Chief Commercial Officer of iRhythm Technologies, executed 2 separate sales totaling 8,510 shares for $1,025,897.50 on May 2, 2025 at an average price of $120.55, reducing his stake by 14.6% to 49,930 shares. This sale occurred as the stock reached its 52-week high of $135.76 (15 cents above the prior peak), reflecting a significant 35.3% gain over the preceding 30 days and 22.5% over 90 days. Patterson's cross-ticker track record shows 3 prior open-market sells with a 100.00% well-timed rate and -7.4% average 30-day return, suggesting a pattern of selling into strength; however, at IRTC specifically, his 2 most recent sells (February 2025) have not yet accumulated sufficient time to measure 90-day outcomes. The company remains unprofitable (net income -$30.7M on $158.7M quarterly revenue) despite 20.1% annual revenue growth, creating a backdrop where insider liquidation into a 52-week peak warrants attention to conviction levels and near-term momentum expectations.

August 2024
low
Buy
280 shares
$20,994
Significance 4/10

CCO Patterson Chad bought 280 shares of IRTC at $74.98 on 2024-05-31 for $20,994.40

Patterson Chad, Chief Commercial Officer at iRhythm Technologies, purchased 280 shares at $74.98 on 2024-05-31, increasing his holdings from 39,865 to 40,145 shares. The purchase represents a modest 0.7% addition to his existing position. As a CCO, this transaction occurs within the natural context of an executive maintaining ownership in the company; however, the relatively small dollar amount ($20,994.40) and incremental share increase provide limited insight into conviction-level or strategic intent regarding the stock's valuation.

Related insiders